Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
It is the first membrane-permeable, selective inhibitor of nicotinamide N-methyltransferase (NNMT), developed at the University of Texas in 2017
When comparisons were made, all relevant treatment groups were included
Injections may be considered when there is a risk of rapid deterioration, significant neurological or haematological concern, or problems taking oral treatment reliably
The absorption process requires adequate stomach acid, intrinsic factor production, and healthy small intestine function
US$ 24.39
US$ 22.07
US$ 23.19
US$ 28.91
US$ 27.87
US$ 21.66
US$ 24.46
US$ 24.57
